If someone has a heart attack and hasn’t taken cholesterol drugs before, waiting more than 12 weeks to start a drug called ezetimibe might increase their risk of future heart problems — though the data isn’t strong enough to be sure.

59

Pro

0

Against

Evidence from Studies

Supporting (1)

59

Community contributions welcome

59

Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry.

Cohort Study

Human

2025 Apr 22

The study found that starting ezetimibe more than 12 weeks after a heart attack was linked to a slightly higher risk of heart problems over 3 years, but the difference wasn’t strong enough to rule out chance. This matches the claim.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry.

Score: 59

DOI: 10.1016/j.jacc.2025.02.007

Similar Assertions

If someone has a heart attack and starts taking a cholesterol drug called ezetimibe within 3 months, they’re less likely to have another heart problem in the next 3 years compared to those who wait longer or never start it.

59

0

90%

If you've had a heart attack, starting a cholesterol drug called ezetimibe within 3 months might lower your chance of dying from heart problems over the next 3 years, compared to waiting or not taking it at all.

59

0

84%

Out of nearly 36,000 people hospitalized for heart attacks, most didn't get a cholesterol drug called ezetimibe—even though almost all were already on strong statins. Only about 1 in 6 got it early, and a similar number got it later.

59

0

81%

For people who've had a recent heart problem, taking ezetimibe with their cholesterol medicine (a statin) helps prevent heart attacks and strokes over 7 years — and doesn't seem to cause extra cancer or liver issues.

0

1

80%

People who had a heart attack and started taking a cholesterol drug called ezetimibe early had fewer heart problems over the next year compared to those who started later or didn’t take it at all.

59

0

71%